CIK 0001710340 · Non-accelerated filer<br>Smaller reporting company
Eton Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ETON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371858472
- Phone
- (847) 787-7361
- Business address
- 21925 W. FIELD PARKWAY, SUITE 235, DEER PARK, IL, 60010-7278
- 4 Open-market sale Director sold 80,555 shares at an average $66.35 ($5,345,072)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Other events
- 8-K Event Material agreement · Acquisition or sale completed
- 4 Open-market sale Chief Business Officer sold 4,166 shares at $55.07 ($229,406)
- 144 Insider Sale of Securities
- 8-K Event Other events
- 4/A Open-market sale Director sold 50,000 shares at an average $59.07 ($2,953,572)
- 4 Open-market sale Director sold 50,000 shares at an average $59.07 ($2,953,572)
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Business Officer sold 25,000 shares at $65.07 ($1,626,750)
- 144 Insider Sale of Securities
- 4 Open-market sale President & CEO sold 100,000 shares at an average $60.88 ($6,087,773)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
Page 1 of 22 · 425 filings